We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
Cap. Flow
-$587M
Cap. Flow %
-4.35%
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38

Top Buys

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$30.1M
2
ET icon
Energy Transfer Partners
ET
+$24.7M
3
FLJP icon
Franklin FTSE Japan ETF
FLJP
+$11.8M
4
WFC icon
Wells Fargo
WFC
+$9.66M
5
ALKS icon
Alkermes
ALKS
+$8.97M

Sector Composition

Rank Sector Weight
1 Energy 65.41%
2 Financials 7.05%
3 Healthcare 3.6%
4 Consumer Discretionary 3.1%
5 Technology 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TKC icon
476
Turkcell
TKC
$4.84B
$664K ﹤0.01%
121,151
+20,475
+20% +$106K
CNST
477
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$663K ﹤0.01%
+54,000
New +$601K
HI
478
DELISTED
Hillenbrand
HI
$662K ﹤0.01%
16,741
REX icon
479
REX American Resources
REX
$1.46B
$661K ﹤0.01%
54,432
+27,510
+102% +$360K
FLR icon
480
Fluor
FLR
$7.29B
$660K ﹤0.01%
19,593
-358
-2% -$12K
ED icon
481
Consolidated Edison
ED
$41.6B
$659K ﹤0.01%
7,515
-762
-9% -$65.6K
UDR icon
482
UDR
UDR
$12.9B
$641K ﹤0.01%
14,269
-1,259
-8% -$56.7K
VRTU
483
DELISTED
Virtusa Corporation
VRTU
$636K ﹤0.01%
14,312
RDY icon
484
Dr. Reddy's Laboratories
RDY
$9.82B
$635K ﹤0.01%
84,720
-1,425
-2% -$11.2K
WLDN icon
485
Willdan Group
WLDN
$1.1B
$633K ﹤0.01%
16,987
+8,585
+102% +$310K
CNNE icon
486
Cannae Holdings
CNNE
$647M
$632K ﹤0.01%
21,800
-194,100
-90% -$5.12M
AVAV icon
487
AeroVironment
AVAV
$7.57B
$627K ﹤0.01%
11,046
+4,393
+66% +$289K
SIX
488
DELISTED
Six Flags Entertainment Corp.
SIX
$622K ﹤0.01%
12,512
+187
+2% +$9.65K
PAC icon
489
Grupo Aeroportuario del Pacifico
PAC
$12.9B
$621K ﹤0.01%
5,955
-1,375
-19% -$139K
RIG icon
490
Transocean
RIG
$5.92B
$610K ﹤0.01%
95,205
+6,444
+7% +$47.9K
KAMN
491
DELISTED
Kaman Corp
KAMN
$610K ﹤0.01%
9,575
-5,181
-35% -$311K
NOV icon
492
NOV
NOV
$7.45B
$609K ﹤0.01%
27,402
+558
+2% +$13.5K
TELL
493
DELISTED
Tellurian Inc.
TELL
$609K ﹤0.01%
77,609
-9,357
-11% -$83.2K
HZO icon
494
MarineMax
HZO
$800M
$608K ﹤0.01%
37,013
BR icon
495
Broadridge
BR
$17.2B
$607K ﹤0.01%
4,751
-3,654
-43% -$440K
AAN.A
496
DELISTED
The Aaron's Company Inc Class A
AAN.A
$607K ﹤0.01%
9,882
-6,350
-39% -$390K
CNR
497
DELISTED
Cornerstone Building Brands, Inc.
CNR
$604K ﹤0.01%
103,539
+7,152
+7% +$39.7K
CNCE
498
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$598K ﹤0.01%
49,799
-6,791
-12% -$73K
WIT icon
499
Wipro
WIT
$18.5B
$597K ﹤0.01%
275,848
-50,600
-16% -$111K
SCSC icon
500
Scansource
SCSC
$1.12B
$595K ﹤0.01%
18,276
-605
-3% -$20.6K

Similar funds

ALPS Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.

  • ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
  • ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
  • ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
  • ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
  • ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
  • ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
  • ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.